Search for: "Teva USA" Results 1 - 20 of 712
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2022, 7:04 am by AMANDA JAMES - MEDCITY NEWS
The post New York AG: Teva USA’s Parent Company Shouldn’t Be Allowed To Escape Opioid Liability appeared first on Above the Law. [read post]
10 Feb 2014, 7:01 pm by H. Scott Leviant
Teva Pharmaceuticals USA, Inc. was described as the end of the world by business interests when the Ninth Circuit held that attorneys could avoid CAFA removal by filing separate cases with fewer than 100 plaintiffs in each case to avoid the mass action provision in CAFA. [read post]
29 Jul 2013, 9:26 pm by Patent Docs
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]
14 Sep 2007, 2:50 pm
USA, No. 05-1887 (D.N.J. 2007) Novartis and Teva have been in litigation over Teva's ANDA for generic Famvir (famciclovir), Novartis's antiviral treatment for herpes, since 2005. [read post]
14 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- On Wednesday, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
12 Oct 2010, 9:59 pm by Patent Docs
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
17 Jul 2022, 9:15 am by Matthew Schutte
On July 11, Teva Pharmaceuticals USA filed a Petition for Writ of Certiorari to the U.S. [read post]
6 Aug 2014, 1:28 pm
Teva Pharmaceuticals USA, Inc. et al, the plaintiff alleged that metoclopramide, the generic name for Relgan, caused her to develop the neurologic condition known as tardive dyskinesia. [read post]
A New York jury found Teva Pharmaceuticals USA, an opioid manufacturer, liable on Thursday for public nuisance by way of inundating the state with pills that killed thousands of people. [read post]
23 Dec 2021, 8:48 pm by Patent Docs
One such decision arose earlier this month when the Federal Circuit affirmed a determination of non-obviousness by the Patent Trial and Appeal Board in an inter partes review proceeding, that opinion captioned Teva Pharmaceuticals USA, Inc. v. [read post]
17 Apr 2014, 12:49 pm by Lyle Denniston
Teva Pharmaceuticals USA, Inc., the maker of a widely used drug for treating multiple sclerosis, told the Supreme Court on Thursday that it is willing to put aside promptly up to $500 million to cover marketing losses that generic competitors might have if Teva succeeds in keeping them on the sidelines for months with their lower-priced alternative versions of the drug. [read post]
30 Aug 2020, 10:19 am by Ben Vernia
According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]